Form 4 for CRDF Cardiff Oncology, Inc.
Accepted 2022-09-19 00:00:00 ET · period of report 2022-09-15 · accession 0001628280-22-025101 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-09-19 | 2022-09-15 | CRDF | TANNENBAUM RENEE P | Dir | P - Purchase | $1.72 | +10.0K | 10.0K | New | +$17.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-15 | P | A | 6,400 | $1.72 | 6,400 | D | — | — | |
| 2 | Common | Common Stock | 2022-09-15 | P | A | 3,600 | $1.72 | 10,000 | D | — | — |